omeprazole and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

omeprazole has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hollenberg, MD; Irimajiri, K; Kawabata, A; Kawai, K; Kawao, N; Kuroda, R; Nishida, S; Nishikawa, H; Sakaguchi, Y; Tagome, A	1

Other Studies

1 other study(ies) available for omeprazole and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

Article	Year
Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion. British journal of pharmacology, 2002, Volume: 135, Issue:5 Topics: Animals; Atropine; Capsaicin; Gastric Mucosa; Immunohistochemistry; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Omeprazole; Pepsin A; Pepsinogen A; Rats; Rats, Wistar; Receptor, PAR-2; Receptors, Thrombin; Stomach	2002

Article

Year

Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion.

British journal of pharmacology, 2002, Volume: 135, Issue:5

Topics: Animals; Atropine; Capsaicin; Gastric Mucosa; Immunohistochemistry; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Omeprazole; Pepsin A; Pepsinogen A; Rats; Rats, Wistar; Receptor, PAR-2; Receptors, Thrombin; Stomach

2002